Skip to main content Help with accessibility Skip to main navigation

TOFACITINIB film-coated tablets (Xeljanz®▼) for Psoriatic Arthritis

CCG Approval Status:

Date Added: 30 - Nov - 2018
Body System:

The Pan Mersey Area Prescribing Committee recommends the prescribing of TOFACITINIB tablets (Xeljanz®▼), by specialists only, for treating psoriatic arthritis after inadequate response to DMARDs in accordance with NICE TA543.